KR101842577B1 - Method preparing the Herbal Medicine Mixture through Cryogenic Micro Grinding Technology - Google Patents

Method preparing the Herbal Medicine Mixture through Cryogenic Micro Grinding Technology Download PDF

Info

Publication number
KR101842577B1
KR101842577B1 KR1020160125605A KR20160125605A KR101842577B1 KR 101842577 B1 KR101842577 B1 KR 101842577B1 KR 1020160125605 A KR1020160125605 A KR 1020160125605A KR 20160125605 A KR20160125605 A KR 20160125605A KR 101842577 B1 KR101842577 B1 KR 101842577B1
Authority
KR
South Korea
Prior art keywords
powder
particle size
delete delete
herb
mixture
Prior art date
Application number
KR1020160125605A
Other languages
Korean (ko)
Inventor
이은정
Original Assignee
제이씨나노텍(주)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제이씨나노텍(주) filed Critical 제이씨나노텍(주)
Priority to KR1020160125605A priority Critical patent/KR101842577B1/en
Application granted granted Critical
Publication of KR101842577B1 publication Critical patent/KR101842577B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/80Scrophulariaceae (Figwort family)
    • A61K36/804Rehmannia
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/234Cnidium (snowparsley)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/65Paeoniaceae (Peony family), e.g. Chinese peony
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Abstract

The present invention relates to a method for producing a medicinal herb mixture ensuring enhanced extractable content of insoluble components by pulverizing herb medicinal ingredients into microparticles using a cryogenic micro grinding technology (CMGT). According to the present invention, by using the CMGT, four types of herb medicinal ingredients included in a Samultang (a traditional medicine for premenstrual and menopausal syndrome in women) can be obtained, which are: Rehmanniae Radix Preparata powder with particle size of 5-10 μm; Paeonia japonica (Makino) Miyabe & Takeda powder with particle size of 4-8 μm; cnidium powder with particle size of 3-7 μm; and dong quai powder with particle size of 3-7 μm. The obtained herb medicinal herb mixture has high extractable content of insoluble and lipophilic components of Rehmanniae Radix Preparata, Paeonia japonica (Makino) Miyabe & Takeda, cnidium, and dong quai, thereby maximizing effectiveness of herb medicinal ingredients.

Description

극저온 초미세분쇄를 이용한 한약재 혼합물의 제조방법 {Method preparing the Herbal Medicine Mixture through Cryogenic Micro Grinding Technology}TECHNICAL FIELD The present invention relates to a method for preparing a mixture of herbal medicines using ultrafine pulverization,

본 발명은 극저온 초미세분쇄법(Cryogenic Micro Grinding Technology: CMGT)을 이용하여 한약재를 마이크로 입자로 분쇄함으로써, 불용성 성분의 추출 함량을 증가시킨 한약재 혼합물의 제조방법에 관한 것이다. The present invention relates to a method for preparing a mixture of herbal medicines by pulverizing herb medicines with microparticles using a cryogenic microgrinding technology (CMGT), thereby increasing the extraction amount of insoluble components.

오늘날 웰빙 문화에 발맞춰, 여러 가지의 한약재 중 몇 가지를 혼합하여 제조된 탕을 복용하여 건강을 증진시키는 움직임이 활발하게 나타나고 있다.In line with today's well-being culture, there is an active movement to promote health by taking a bath made of a mixture of several herbal medicines.

예를 들어, 최근 이슈화되고 있는 '사물탕'은 당귀, 숙지황, 천궁, 백작약의 4가지 약재 성분을 혼합하여 제조된 탕으로, 피를 생성하고 피의 흐름을 좋게 하는 보혈제로서 생리불순과 하복부의 냉기를 없애주며, 출산후 자궁내의 어혈을 풀어주기도 하고 성장기 여자의 자궁 발육을 도와주기도 하여 여성들이 많이 복용하고 있다.For example, 'Sam-tang', which has been recently published, is a mixture of four kinds of medicinal ingredients, namely, Angelica japonica, Sukjwanghwang, Tanggung, and Baekjaek. It is a blood-forming agent that produces blood and improves blood flow. It helps to remove the eosinophilia in the uterus after delivery and helps the uterus of the growing female.

그러나, 사물탕과 같이 복수의 한약재를 혼합하여 제조하는 탕은 복용성과 편리성이 좋지 않아 일상 생활에서 가까이 두고 복용하기가 쉽지 않다는 문제점이 있다.However, there is a problem that it is not easy to take the hot water, which is prepared by mixing a plurality of herbal medicines such as sametang, because it is poor in convenience and convenience in daily life.

한편, 한약재의 주요 생리활성 성분은 대부분 지용성 물질인데, 전통적인 열수 추출 방식으로 얻어진 한약 중탕액은 한약재에 포함되어 있는 수용성 물질만 추출되고, 불용성, 지용성 물질은 열수 추출 시 제대로 용해되지 못하고 폐기물로 버려지는 문제점이 있다.On the other hand, most of the physiologically active ingredients of medicinal herbs are mostly lipophilic substances. The herbal medicinal herb liquid obtained by the conventional hot water extraction method only extracts the water-soluble substances contained in the medicinal herbs. Insoluble and lipophilic substances are not dissolved properly in the hot water extraction, There is a problem.

이에, 본 발명자는 등록특허 제 10-1592432호로 특허등록받았던 극저온 초미세분쇄 기술을 이용하여 이러한 문제점을 해결하고자 한다.Accordingly, the present inventor intends to solve such a problem by using a cryogenic ultra-fine grinding technique which has been patented as a registered patent No. 10-1592432.

여기서, 등록특허 제 10-1592432호로 특허등록받았던 극저온 초미세분쇄 기술은 야채 또는 과일을 -70 ~ -150℃ 에서 15 ~ 40㎛의 크기로 냉동분쇄하고, -190~-200℃의 액체질소를 분사하여 급속냉동시키는 단계를 포함하는 과채류 블록제조방법에 관하여 것으로, 본 발명자는 이 기술을 이용하여 한약재의 주요 성분들을 충분히 추출하여 한약재의 효과를 극대화시킬 수 있고, 기존의 한약재보다 용이하게 이를 섭취할 수 있도록 하는 초미세 분말화된 한약재 혼합물을 완성하게 되었다.Here, the cryogenic ultra-fine grinding technique, which has been patented in Patent No. 10-1592432, is a method in which vegetable or fruit is frozen and pulverized at a temperature of -70 to -150 캜 to a size of 15 to 40 탆, liquid nitrogen at -190 to -200 캜 The present inventors have succeeded in extracting the main ingredients of herb medicine by using this technique to maximize the effect of herb medicine and to make it easier to ingest the herb medicine than the conventional herb medicine. To make an ultrafine powdered herbal medicine mixture.

본 발명의 목적은 극저온 초미세분쇄법(Cryogenic Micro Grinding Technology: CMGT)을 이용하여 한약재를 마이크로 입자로 분쇄함으로써, 불용성 성분의 추출 함량을 증가시킨 한약재 혼합물의 제조방법을 제공하는 데 있다.An object of the present invention is to provide a method for preparing a mixture of herbal medicines by pulverizing herb medicines with microgranules using a cryogenic micro grinding technology (CMGT) to increase the extractable content of insoluble components.

본 발명은 상기 목적을 달성하기 위하여, 숙지황을 -130℃ 내지 -160℃에서 평균입도5 내지 10㎛의 크기로 냉동분쇄하여 숙지황 초미세분말을 수득하는 단계; 백작약을 -95℃ 내지 -120℃에서 평균입도 4 내지 8㎛의 크기로 냉동분쇄하여 백작약 초미세분말을 수득하는 단계; 천궁을 -90℃ 내지 -100℃에서 평균입도 3 내지 7㎛의 크기로 냉동분쇄하여 천궁 초미세분말을 수득하는 단계; 및 당귀를 -90℃ 내지 -100℃에서 평균입도 3 내지 7㎛의 크기로 냉동분쇄하여 당귀 초미세분말을 수득하는 단계를 포함하는 상기 숙지황, 백작약, 천궁 및 당귀의 초미세분말 혼합물을 제조하는 방법을 제공한다.In order to attain the above object, the present invention provides a method for preparing a safflower-like ultrafine powder by freezing grinding safflower at a temperature of -130 ° C. to -160 ° C. to an average particle size of 5 to 10 μm; Freezing powder at a temperature of -95 ° C to -120 ° C to an average particle size of 4 to 8 μm to obtain ultrafine powdered whey powder; Freezing and crushing the mantle to a size of 3-7 占 퐉 at an average particle size of -90 占 폚 to -100 占 폚 to obtain an ultramarine ultrafine powder; And Angelica keiskei koidz. At an average particle size of from 3 to 7 mu m at a temperature of from -90 DEG C to -100 DEG C to obtain an Angelica gigas superfine powder, ≪ / RTI >

이때, 상기 숙지황, 백작약, 천궁 및 당귀의 초미세분말 혼합물을 제조하는 방법은 상기 숙지황, 백작약, 천궁 및 당귀 각각을 수득하는 단계를 포함하는 한약재 혼합물의 제조방법으로 본 발명을 해석할 수 있음은 물론이다.In this case, the method for preparing the ultrafine powder mixture of Sulfur Sulfur, Veterinary Sulfate, Astragalus membranaceus and Angelica gigas can be interpreted as a method for preparing the medicinal herb mixture comprising the steps of obtaining each of Sulfur, Sulfur, Of course.

이와 같은 본 발명에 따른 초미세분말, 즉 한약재 혼합물은 숙지황, 백작약, 천궁 또는 당귀의 지용성 성분의 함량이 증가된 것을 특징으로 할 수 있고, 상기 지용성 성분은 디메틸스베로신(Demethylsuberosine), Z-리구스틸라이드(Z-Ligustilide), 데커신(Decursin) 및 데커시놀 안젤레이트(Decursinol angelate)로 구성된 군에서 선택되는 어느 하나인 것을 특징으로 할 수 있다.The ultrafine powder according to the present invention, i.e., the herbal medicine mixture, may be characterized in that the fat-soluble component of Sulfur Sulfur, Baekjanggi, Tanggu, or Angelica gigas is increased, and the fat-soluble component is selected from the group consisting of Demethylsuberosine, And may be any one selected from the group consisting of Z-Ligustilide, Decursin and Decursinol angelate.

한편, 본 발명은 상기 방법으로 얻어진 초미세분말 혼합물, 즉 한약재 혼합물을 포함하는 염증질환 예방 또는 치료용/개선용 약학 조성물 및 건강기능식품을 제공한다.Meanwhile, the present invention provides a pharmaceutical composition for preventing or treating inflammatory diseases, a pharmaceutical composition for improving / treating inflammation diseases, and a health functional food comprising the mixture of ultrafine powder obtained by the above method, i.e., a mixture of herbal medicines.

본 발명에 있어서, 상기 약학 조성물은 경구, 피하, 정맥 내, 근육 내, 비강 내 또는 복강 내로 투여될 수 있고, 정제, 캡슐제, 과립제, 환제, 시럽제, 액제, 유제, 현탁제 또는 주사제의 형태로 제조될 수 있다. 상기 건강기능식품은 담체, 희석제, 부형제 및 첨가제 중 하나 이상을 더 포함하여 정제, 환제, 산제, 과립제, 분말제, 캡슐제 및 액제 제형으로 이루어진 군에서 선택된 하나로 제형될 수 있다.In the present invention, the pharmaceutical composition may be administered orally, subcutaneously, intravenously, intramuscularly, intranasally or intraperitoneally and may be in the form of tablets, capsules, granules, pills, syrups, solutions, emulsions, suspensions, . ≪ / RTI > The health functional food may be formulated into one selected from the group consisting of tablets, pills, powders, granules, powders, capsules and liquid formulations, further comprising at least one of carriers, diluents, excipients and additives.

본 발명에 따르면 사물탕에 포함되는 4가지 한약재를 극저온 초미세분쇄법을 이용하여 입도 5~10㎛의 숙지황 분말, 입도 4~8㎛의 백작약 분말, 입도 3~7㎛의 천궁 분말, 입도 3~7㎛의 당귀 분말을 얻을 수 있고, 얻어진 한약재 혼합물은 숙지황, 백작약, 천궁 및 당귀의 불용성, 지용성 성분의 추출 함량이 높아 약재의 효과를 극대화할 수 있다.According to the present invention, four medicinal herbs contained in a sweet pot are prepared by cryogenic superfine pulverization. The powder is classified into 5 ~ 10 ㎛ seed powder, 4 ~ 8 ㎛ seed powder, 3 ~ 7 ㎛ seed powder, And the resulting herbal medicine mixture has a high extractable content of insoluble and fat-soluble components of Sulfur Sulfur, Baekjanggi, Gyungguk, and Angelica giganta, so that the effect of the medicinal ingredient can be maximized.

도 1은 극저온 초미세분말법을 이용하여 한약재 혼합물, 더욱 구체적으로는 사물탕 미세분말을 제조하는 공정을 나타낸 것이다.
도 2는 열수 추출을 통한 사물탕 중탕액의 HPLC 분석 결과를 나타낸 것이다.
도 3은 극저온 초미세분말법을 이용한 사물탕 미세분말의 HPLC 분석 결과를 나타낸 것이다.
1 shows a process for preparing a mixture of herbal medicines using a cryogenic ultra-fine finely divided powder, more specifically, a fine powder of safflower.
FIG. 2 shows the results of HPLC analysis of Sam's hot water extract through hot water extraction.
FIG. 3 shows the results of HPLC analysis of the fine powder of Satsumang using the ultra-low temperature micro-finest method.

본 발명은 극저온 초미세분쇄를 이용한 한약재 혼합물의 제조하는 것을 권리범위로 하고 있으나, 더욱 상세한 설명을 위하여, 한약재 혼합물의 한 종류인 사물탕을 예를 들어 설명한다.Although the scope of the present invention is limited to the preparation of a mixture of medicinal herbs using cryogenic superfine pulverization, for the sake of more detailed explanation, a kind of medicinal herb which is one kind of medicinal herb is exemplified.

일반적으로, 사물탕은 당귀, 숙지황, 천궁, 백작약의 4가지 약재 성분을 포함하며, 이 탕은 피를 생성하고 피의 흐름을 좋게 하는 보혈제로서 생리불순과 하복부의 냉기를 없애주며, 출산 후 자궁내의 어혈을 풀어주기도 하고 성장기 여자의 자궁 발육을 도와주기도 하는 여성들에게 잘 어울리는 탕이다.Generally, Sam-tang contains four medicinal ingredients: Angelica japonica, Silla japonica, Silla japonica, and Veterinary Medicine. It is a blood-forming agent that produces blood and improves blood flow. It eliminates menstrual irregularities and chills in the lower abdomen. And it helps women who are growing up to help their uterus grow well.

여기서, 당귀(Angelicae Gigantis Radix)는 산형과(Umbelliferae)의 여러해살이풀인 당귀(Angelica sinensis D.)로, 한국에서는 당귀(Angelicae gigas), 왜당귀 (Ligusticum acutilobum)를 약용으로 사용한다. 함유성분으로는 주성분인 버갑텐 (Bergaptene), 부틸리덴프탈리드(butylidenephthalide)와 함께 지방유, 비타민(vitamin)류 물질 등이 있고, 진통ㆍ배농ㆍ지혈ㆍ강장작용이 있으므로 복통ㆍ종기ㆍ타박상 및 부인병에 이용되고 있다.Here, Angelicae Gigantis Radix is Angelica sinensis D., a perennial plant of Umbelliferae, and Angelicae gigas and Ligusticum acutilobum are medicines in Korea. The ingredients are mainly fatty substances such as Bergaptene, butylidenephthalide, and fatty substances and vitamins, and have analgesic, drainage, hemostatic, and tonic effects. Therefore, It is used for women's diseases.

또한, 천궁(Cnidii Rhizoma)은 향과, 호궁, 경궁, 궁궁이라고도 불리는데, 산형과(Umbelliferae) 다년생 초목인 천궁(Lingustieum chuangxiong, Cnidium officinale)의 뿌리를 말린 것으로 혈액과 기를 잘 돌게 하는 대표적인 약재이다. 천궁에는 정유와 크니드리드, 세다노익산, 아미노산, 알카로이드, 페루릭산 등이 함유되어 있으며, 월경통, 부월경, 두통, 복통 등의 증상을 개선시켜 주며, 어지럼, 생리불순, 생리통, 복통, 외상으로 인한 타박상 등에도 사용하며, 약리실험 결과 진정작용, 혈압강하작용, 항균작용, 자궁수축작용 등이 밝혀졌다.Also, Cnidii Rhizoma is also known as incense, horseshoe, horseshoe, and alum (Umbelliferae), a dried herbaceous plant of Lingustieum chuangxiong (Cnidium officinale), which is a representative medicinal product for circulating blood and vegetables. It contains refined oil, cnidriide, cedaroid acid, amino acid, alkaloid and ferulic acid. It improves symptom such as menstrual pain, menstrual cramps, headache, abdominal pain, dizziness, menstrual irregularity, It is also used for bruises due to thalidomide. Pharmacological tests revealed sedation, blood pressure lowering, antibacterial and uterine contraction.

뿐만 아니라, 숙지황(Rehmanninae Rhizoma Preparat)은 현삼과의 여러해살이풀인 지황(Rehmannia glutinosa (Gaertner) Libosch.) 또는 회경지황(R. glutinosa Libosch. var. hueichingensis(Chao et Schih) Hsia.)의 뿌리, 줄기를 쪄서 건조한 것으로 맛은 달면서도 쓴맛이 돌고 따뜻한 성질이 있어 혈을 보하고 정(생명 이 발생하고 활동하는 데 기본이 되는 물질)을 보충해서 허리와 무릎이 시리고 아픈 증상이나 월경이상, 어지럼 증 등을 치료하고 머리를 검게 하는 효능이 있다.In addition, Rehmanninae Rhizoma Preparat is the root of Rehmannia glutinosa (Gaertner Libosch.) Or R. glutinosa Libosch. Var. Hueichingensis (Chao et Schih) Hsia. It is dry with steamed stem. It has a bitter taste and a warm nature while it has a flavor. It has a characteristic of bloating and replenishing the base (substance that is the basis for life and activity) It has the effect of treating the symptoms and darkening the head.

한편, 백작약(Paeoniae Radixa)은 모란과(Paeoniaceae)에 속하는 다년생 식물 작약(Paeonia japonica)의 뿌리로 한방에서 수렴, 완화, 진경, 진통약으로 사용한다. 백작약의 주요 성분으로는 파에오니플로린(paeoniflorin), 옥시 파에오니플로린(oxypaeoniflorin), 벤조일파에오니플로린(benzoylpaeoniflorin), 알비플로린(albiflorin), 파 에오니올(paeoneol) 등이 있다. 백작약은 평활근 이완, 할혈전, 항염증, 항스트레스, 간독성 보호효과가 연구되었으며, 또한 그 분획물에 의한 항암, 면역기능 촉진 효과 등이 보고되었다.On the other hand, Paeoniae Radixa is the root of Paeonia japonica belonging to the peonies and Paeoniaceae and is used as a convergence, relief, shaking and pain medicine in one room. The major components of the veterinary medicine are paeoniflorin, oxypaeoniflorin, benzoylpaeoniflorin, albiflorin, paeoneol, and the like. Anti-inflammatory, anti-stress, and hepatotoxic effects were studied in the peptides, and anti-cancer and immune-promoting effects of the fractions were reported.

이러한 사물탕을 제조하는데 있어서 본 발명에서 이용되는 극저온 초미세분쇄법(Cryogenic Micro Grinding Technology)은 시료를 -190 내지 -200℃의 극저온 상태까지 동결시킨 후 밀가루보다 더 고운 마이크로 입자로 분쇄하는 것으로, 원물의 영양과 맛 그리고 향을 살리면서 초미세입자로 물에 잘 분산되어 음용감이 좋도록 한다.The cryogenic micro grinding technology used in the present invention for producing such a sweet pot is to freeze the sample to a cryogenic temperature of -190 to -200 ° C and then crush the sample into fine particles that are finer than flour, The nutrition, flavor and aroma of the water are utilized, and the water is well dispersed in the water as a micro-tenant so that the drinking feeling is good.

본 발명에 따른 사물탕 극저온 초미세분말의 HPLC 분석 결과에 따르면, 당귀의 디메틸스베로신(Demethylsuberosine), 천궁의 제트-리구스틸라이드(Z-Ligustilide), 당귀의 데커신(Decursin) 및 데커시놀 안젤레이트(Decursinol angelate)와 같은 지용성 성분들이 추출되었다.According to the results of the HPLC analysis of the ultrafine powder of Samtung cryogenic powder according to the present invention, it was confirmed that Demethylsuberosine of Danggui, Z-Ligustilide of Danggu, Dercusin decursin, Lipid soluble components such as decursinol angelate were extracted.

여기서, 데커신은 일본에서 바디나물(Angelica decursiva Fr. et Sav.)의 에테르 추출액으로부터 최초로 분리된 피라노 쿠마린(pyranocoumarin)계열의 천연물 성분으로 분자량이 328.35이며, 분자식이 C19H20O5이다.Here, Decker Shin is a natural component of pyranocoumarin, which was first isolated from the ether extract of Angelica decursiva Fr. et Sav. In Japan. It has a molecular weight of 328.35 and a molecular formula of C 19 H 20 O 5 .

또한, 데커시놀 안젤레이트는 데커신과 동일한 분자량과 동일한 화학식을 가지고 있는 구조이성질체이고, Z-리구스틸라이드는 분자량이 190.24이고 분자식이 C12H14O2 이다. In addition, decascinol angelate is a structural isomer having the same molecular weight and the same chemical formula as decacin, Z-ligustilide has a molecular weight of 190.24 and a molecular formula of C 12 H 14 O 2 .

Figure 112016094675710-pat00001
Figure 112016094675710-pat00001

[사물탕 극저온 초미세분말에서 검출된 화합물][Compound detected in ultrafine powder at a cryogenic temperature of Samarium]

한편, 본 발명에 따른 건강기능식품은 담체, 희석제, 부형제 및 첨가제 중 하나 이상을 더 포함하여 정제, 환제, 산제, 과립제, 분말제, 캡슐제 및 액제 제형으로 이루어진 군에서 선택된 하나로 제형된 것을 특징으로 한다.Meanwhile, the health functional food according to the present invention may be formulated into one selected from the group consisting of tablet, pill, powder, granule, powder, capsule and liquid formulation further comprising at least one of carrier, diluent, excipient and additives .

본 발명의 추출물을 첨가할 수 있는 식품으로는, 각종 식품류, 분말, 과립, 정제, 캡슐, 시럽제, 음료, 껌, 차, 비타민 복합제, 건강기능성 식품류 등이 있다. 상기 본 발명에 더 포함될 수 있는 첨가제로는, 천연 탄수화물, 향미제, 영양제, 비타민, 광물(전해질), 풍미제(합성 풍미제, 천연 풍미제 등), 착색제, 충진제(치즈, 초콜렛 등), 팩트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH조절제, 안정화제, 방부제, 산화 방지제, 글리세린, 알콜, 탄산화제 및 과육으로 이루어진 군으로부터 선택된 1종 이상의 성분을 사용할 수 있다.Examples of foods to which the extract of the present invention can be added include various foods, powders, granules, tablets, capsules, syrups, drinks, gums, tea, vitamin complexes, and health functional foods. Examples of the additive that can be further included in the present invention include natural carbohydrates, flavors, nutrients, vitamins, minerals (electrolytes), flavors (synthetic flavors, natural flavors and the like), colorants, fillers (cheese, At least one component selected from the group consisting of fumaric acid and its salt, alginic acid and its salts, organic acid, protective colloid thickener, pH adjusting agent, stabilizer, preservative, antioxidant, glycerin, alcohol, .

상술한 천연 탄수화물의 예는 모노사카라이드, 예를 들어, 포도당, 과당 등; 디사카라이드, 예를 들어 말토스, 슈크로스 등; 및 폴리사카라이드, 예를 들어 덱스트린, 시클로덱스트린 등과 같은 통상적인 당, 및 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 상기 향미제로서 천연 향미제(타우마틴, 스테비아 추출물(예를 들어 레바우디오시드 A, 글리시르히진등) 및 합성 향미제(사카린, 아스파르탐 등)를 유리하게 사용할 수 있다.Examples of the above-mentioned natural carbohydrates include monosaccharides such as glucose, fructose and the like; Disaccharides such as maltose, sucrose and the like; And polysaccharides, for example, conventional sugars such as dextrin, cyclodextrin and the like, and sugar alcohols such as xylitol, sorbitol and erythritol. Natural flavors (tautatin, stevia extract (e.g., rebaudioside A, glycyrrhizin, etc.) and synthetic flavors (saccharine, aspartame, etc.) can be advantageously used as the flavor.

상기 외에 본 발명에 따른 조성물은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산 음료에 사용되는 탄산화제 등을 함유할 수 있다.In addition to the above, the composition according to the present invention can be used as a flavoring agent such as various nutrients, vitamins, minerals (electrolytes), synthetic flavors and natural flavors, colorants and heavies (cheese, chocolate etc.), pectic acid and its salts, A salt thereof, an organic acid, a protective colloid thickener, a pH adjusting agent, a stabilizer, a preservative, a glycerin, an alcohol, a carbonating agent used in a carbonated drink, and the like.

그 밖에 본 발명에 따른 조성물은 천연 과일 쥬스 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다.In addition, the composition according to the present invention may contain flesh for the production of natural fruit juices and vegetable drinks. These components may be used independently or in combination.

상기 담체, 부형제, 희석제 및 첨가제의 구체적인 예로는 이에 한정하는 것은 아니나, 락토즈, 덱스트로즈, 슈크로즈, 솔비톨, 만니톨, 에리스리톨, 전분, 아카시아 고무, 인산칼슘, 알지네이트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 미세결정성 셀룰로즈, 폴리비닐피롤리돈, 셀룰로즈, 폴리비닐피롤리돈, 메틸셀룰로즈, 물, 설탕시럽, 메틸셀룰로즈, 메틸 하이드록시 벤조에이트, 프로필하이드록시 벤조에이트, 활석, 스테아트산 마그네슘 및 미네랄 오일로 이루어진 그룹으로부터 선택된 1종 이상이 사용되는 것이 바람직하다.Specific examples of the carrier, excipient, diluent and additives include, but are not limited to, lactose, dextrose, sucrose, sorbitol, mannitol, erythritol, starch, acacia rubber, calcium phosphate, alginate, gelatin, calcium phosphate, calcium Silicate, microcrystalline cellulose, polyvinylpyrrolidone, cellulose, polyvinylpyrrolidone, methylcellulose, water, sugar syrup, methylcellulose, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate And a mineral oil are preferably used.

본 발명에 따른 건강기능식품을 제제화할 경우에는 보통 사용하는 충진제, 증량제, 결합제, 습윤제, 붕해제, 계면활성제 등의 희석제 또는 부형제를 사용하여 조제된다. 상기 상술한 제형 내 유효성분으로서의 본 발명에 따른 추출물의 함량은 사용 형태 및 목적, 환자 상태, 증상의 종류 및 경중 등에 의하여 적절하게 조절할 수 있으며, 고형분 중량 기준으로 0.001 내지 99.9 중량%, 바람직하게는 0.01 내지 50 중량%일 수 있으나, 이에 한정되지 않는다.When the health functional food according to the present invention is formulated, it is prepared using diluents or excipients such as fillers, extenders, binders, humectants, disintegrants, surfactants and the like which are usually used. The content of the extract according to the present invention as an active ingredient in the above-described formulation can be appropriately adjusted depending on the mode and purpose of use, the condition of the patient, the type of symptoms and the severity, and is 0.001 to 99.9% by weight, But it is not limited thereto.

한편, 이하에서는 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 하며, 이하에서 제시되는 실시예 또한 전술한 바와 같이 한약재 혼합물의 한 종류인 사물탕에 관한 것으로, 본 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로서, 본 발명의 요지에 따라 본 발명의 범위가 이들 실시예에 의해 제한되지 않는다는 것은 당 업계에서 통상의 지식을 가진 자에게 있어서 자명할 것이다.Hereinafter, the present invention will be described in more detail with reference to the following examples. The following examples also relate to Sam-tang, which is a kind of mixture of herbal medicines, as described above. It will be apparent to those skilled in the art that the scope of the present invention is not limited by these embodiments in accordance with the gist of the present invention.

실시예Example 1 One

사물탕 극저온 초미세분말의 제조Manufacture of ultrafine powder at cryogenic temperature

숙지황 60g을 -130℃ 내지 -160℃에서 평균입도 5 내지 10㎛의 크기로 분쇄하고, 백작약 60g을 -95℃ 내지 -120℃에서 평균입도 4 내지 8㎛의 크기로 분쇄하고, 천궁 60g 을 -90℃ 내지 -100℃에서 평균입도 3 내지 7㎛의 크기로 분쇄하고, 당귀 60g 를 -90℃ 내지 -100℃에서 평균입도 3 내지 7㎛의 크기로 분쇄하였다. 60 g of Suksori was pulverized at an average particle size of 5 to 10 탆 at a temperature of -130 캜 to -160 캜 and 60 g of the pesticide was pulverized at an average particle size of 4 to 8 탆 at a temperature of -95 캜 to -120 캜, At an average particle size of 3 to 7 mu m at 90 DEG C to -100 DEG C, and 60 g of Angelica keiskei koidz. Was crushed to a size of 3 to 7 mu m in average particle size at -90 DEG C to -100 DEG C.

실시예Example 2 2

사물탕 극저온 초미세분말과 사물탕 중탕액의 성분 비교Comparison of components of celestial ultrafine powder and Sam-tan bath

사물탕 중탕액은 숙지황, 백작약, 천궁 및 당귀 각각 60g을 부직포에 넣고, 부직포를 중탕기에 넣은 후 정제수 1.98L를 넣고 100℃에서 2 시간 30분 동안 가열하여 제조하였다. 제조된 사물탕 중탕액과 상기 실시예 1에서 제조된 사물탕 극저온 초미세분말 혼합물의 성분 비교를 위해 HPLC 분석을 수행하였다(Instrument: Agilent HPLC, Column: Phemnomenex Luna 5u C18(2) 100A 150 x 4.60 mm 5micron, Intection volume: 10 μL, Flow rate: 1.0 mL/min, Detection UV: 230 nm, Mobile phase: Water-MeOH Gradient elution). 사물탕 중탕액 시료는 실린지 필터로 필터링 한 후 분석하였고, 사물탕 극저온 초미세분말 시료는 1.21g의 시료에 추출용매 10mL를 첨가한 다음 실린지 필터로 필터링 한 후 분석하였다. 추출용매는 증류수, 50% 메탄올, 100% 메탄올을 사용하였다(메탄올은 한약재의 성분추출에 있어 보편적으로 사용되는 용매임).The Sangmangtang water solution was prepared by putting 60 g of each of Sukjunghwang, Baekjaejeon, Kyeongguk, and Angelicae into a nonwoven fabric, adding 1.98 L of purified water after putting the nonwoven fabric into a stool, and heating at 100 ° C for 2 hours and 30 minutes. HPLC analysis was performed for the comparison of the composition of the prepared Sangam hot water solution and the mixture of the silicate cryogenic ultrafine powder prepared in Example 1 (Instrument: Agilent HPLC, Column: Phemnomenex Luna 5u C18 (2) 100A 150 x 4.60 mm 5micron , Intection volume: 10 μL, Flow rate: 1.0 mL / min, Detection UV: 230 nm, Mobile phase: Water-MeOH Gradient elution). The sample of Sangmangtang was analyzed by syringe filter and analyzed. Sodium cryo-ultrafine powder samples were analyzed by adding 10mL of extraction solvent to 1.21g of sample and filtering with syringe filter. Distilled water, 50% methanol and 100% methanol were used as extraction solvents. (Methanol is a widely used solvent for extraction of herbal ingredients).

그 결과, 사물탕 중탕액에서는 숙지황의 5-HMF, 백작약의 파에오니플로린(Paeoniflorin), 당귀의 노다케닌(Nodakenin)이 검출되었고, 사물탕 극저온 초미세분말 시료를 물로 추출한 경우에는 사물탕 중탕액과 유사한 결과가 나타났다. 사물탕 극저온 초미세분말 시료에 메탄올을 첨가하여 추출한 경우에는 당귀의 디메틸스베로신(Demethylsuberosine), 천궁의 Z-리구스틸라이드(Z-Ligustilide), 당귀의 데커신(Decursin) 및 데커시놀 안젤레이트(Decursinol angelate) 화합물이 검출되었다. 하기 표 1에 검출된 화합물의 pak area 값을 나타내었다.5-HMF, Paeoniflorin, and Nodakenin were detected in the Sangmang-tang water bath. In the case of extracting ultrafine powder samples of Sam-tang cryogenic temperature, . When methanol was added to the sample at the cryogenic temperature ultrafine powder, the content of demethylsuberosine, Z-Ligustilide, decursin and decursin, (Decursinol angelate) compound was detected. The pak area values of the detected compounds are shown in Table 1 below.

5-HMF5-HMF 파에오니플로린Paeonia florin 노다케닌Noda cannine 디메틸스베로신Dimethylsuberosine 리구스틸라이드Ligustylide 데커신
및 데커시놀 안젤레이트
Decker Shin
And dexacinol angelate
사물탕 중탕액Sankamang 257.6257.6 702.4702.4 227.5227.5 N.DN.D. N.DN.D. 41.341.3 사물탕
극저온 초미세
분말
Samantang
Cryogenic ultra fine
powder
물 추출Water extraction 134.3134.3 911.5911.5 114.3114.3 N.DN.D. 21.921.9 72.972.9
50% 메탄올 추출50% methanol extract 128.2128.2 958.2958.2 124.2124.2 71.271.2 326.5326.5 4403.84403.8 100% 메탄올 추출100% methanol extract 118.4118.4 532.5532.5 125.7125.7 226.0226.0 376.4376.4 5621.25621.2

Claims (12)

(a) 숙지황을 -130℃ 내지 -160℃에서 평균입도 5 내지 10㎛의 크기로 냉동분쇄하여 숙지황 초미세 분말을 수득하는 단계;
(b) 백작약을 -95℃ 내지 -120℃에서 평균입도 4 내지 8㎛의 크기로 냉동분쇄하여 백작약 초미세 분말을 수득하는 단계;
(c) 천궁을 -90℃ 내지 -100℃에서 평균입도 3 내지 7㎛의 크기로 냉동분쇄하여 천궁 초미세 분말을 수득하는 단계;
(d) 당귀를 -90℃ 내지 -100℃에서 평균입도 3 내지 7㎛의 크기로 냉동분쇄하여 당귀 초미세 분말을 수득하는 단계를 포함하고, 상기 한약재 초미세 분말을 메탄올 추출하는 경우에 추출되는 지용성 성분의 함량이 증가하는 것을 특징으로 하는 한약재 혼합물의 제조방법.
(a) freezing grind slurry at a temperature of -130 캜 to -160 캜 at an average particle size of 5 to 10 탆 to obtain ultramarine ultrafine powder;
(b) cryoprotecting the vinegar at a temperature of -95 ° C to -120 ° C to an average particle size of 4 to 8 μm to obtain ultrafine powdery fine powder;
(c) cryogenically crushing the crown to a size of from 3 to 7 mu m at a temperature of from -90 DEG C to -100 DEG C to obtain a celestial ultrafine powder;
(d) freezing and crushing the Angelica gigas at an average particle size of 3 to 7 占 퐉 at a temperature of -90 占 폚 to -100 占 폚 to obtain Angelica giga fin powder, wherein the ultrafine powder of the herbal medicine is extracted Wherein the content of the fat-soluble ingredient is increased.
삭제delete 삭제delete 삭제delete 삭제delete 제1항에 있어서,
상기 지용성 성분은,
디메틸스베로신(Demethylsuberosine), Z-리구스틸라이드(Z-Ligustilide), 데커신(Decursin) 및 데커시놀 안젤레이트(Decursinol angelate)로 구성된 군에서 선택되는 어느 하나인 것을 특징으로 하는,
한약재 혼합물의 제조방법.
The method according to claim 1,
The fat-
Characterized in that it is any one selected from the group consisting of demethylsuberosine, Z-Ligustilide, Decursin and Decursinol angelate.
A method for preparing a mixture of herbal medicines.
삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete
KR1020160125605A 2016-09-29 2016-09-29 Method preparing the Herbal Medicine Mixture through Cryogenic Micro Grinding Technology KR101842577B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020160125605A KR101842577B1 (en) 2016-09-29 2016-09-29 Method preparing the Herbal Medicine Mixture through Cryogenic Micro Grinding Technology

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160125605A KR101842577B1 (en) 2016-09-29 2016-09-29 Method preparing the Herbal Medicine Mixture through Cryogenic Micro Grinding Technology

Publications (1)

Publication Number Publication Date
KR101842577B1 true KR101842577B1 (en) 2018-05-14

Family

ID=62188066

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160125605A KR101842577B1 (en) 2016-09-29 2016-09-29 Method preparing the Herbal Medicine Mixture through Cryogenic Micro Grinding Technology

Country Status (1)

Country Link
KR (1) KR101842577B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3838284A4 (en) * 2019-10-31 2022-11-23 Curome Biosciences Co., Ltd. Composition, comprising salvia miltiorrhiza bunge extract as active ingredient, for prevention or treatment of benign prostatic hyperplasia or alopecia

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
김은경 외 6명. 사물탕이 알러지 염증반응에 미치는 영향. 제21권 제3호. 2007년, pp.617-625*
박지영 외 6명. 쌍화탕 추출물이 항산화효소 및 항노화관련 효소 활성에 미치는 영향. 제27권 제3호. 2012년 5월, pp. 67-74*

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3838284A4 (en) * 2019-10-31 2022-11-23 Curome Biosciences Co., Ltd. Composition, comprising salvia miltiorrhiza bunge extract as active ingredient, for prevention or treatment of benign prostatic hyperplasia or alopecia

Similar Documents

Publication Publication Date Title
US8747917B2 (en) Composition comprising Cudrania tricuspidata and Coix lachryma-jobi for suppressing obesity or lowering blood sugar, and use thereof
KR101392204B1 (en) Composition comprising herbal extract of red ginseng, Angelicae gigantis Radix, citrus peel and green tea leaves for treating or preventing vascular diseases
KR20150096798A (en) Pharmaceutical composition for treating headache, and preparation method thereof
KR101077523B1 (en) A composition comprising the extract of crude drug selected from Eriobotryae Folium and Dendropanax morbiferafor treating and preventing neuro-degenerative disease
KR102045903B1 (en) Composition for improving premenstrual syndrome symptom comprising extract of Chrysanthemum zawadskii
KR100771524B1 (en) Composition for improving liver function comprising herbal mixture extract
KR101975599B1 (en) Compositions for Protecting or Treating Cancer
KR20110127443A (en) Composition for anti-obesity and antioxidant comprising camellia japonica flower extract as active ingredient
KR100771525B1 (en) Composition for removing hangover comprising herbal mixture extract
KR20150037109A (en) Manufacturing method of composition of health food containing wild ginseng and herb extracts and composition of health food containing wild ginseng and herb extracts manufactured by the same
KR102197183B1 (en) Food composition and Pharmaceutical composition for activation of anti-oxidant, anti-inflammatory or immunity comprising hot water extract of Angelica gigas nakai, Cnidium officinale makino, Paeonia lactiflora and extract of Red ginseng or extract of Gapi taheebo
KR101842577B1 (en) Method preparing the Herbal Medicine Mixture through Cryogenic Micro Grinding Technology
KR101039110B1 (en) A water composition comprising Broussonetia kazinoki Sieb. for immunopotentiating
KR102331317B1 (en) Composition for improving premenstrual syndrome symptom comprising compounds isolated from Chrysanthemum zawadskii extract
KR101416191B1 (en) Pharmaceutical composition for preventing or treating cancer comprising extract of Jeju traditional citrus Palsac, Dangyusa or Iyegam as effective component
EP2438924B1 (en) Pharmaceutical composition containing herbal extracts for preventing or treating nephritis
KR102099147B1 (en) Composition for preventing, ameliorating or treating obesity comprising Heracleum moellendorffii root and Torilis japonica mixed extract as effective component
KR20100009151A (en) Composition containing mixture extract of saururus chinesis and scutellaria baicalensis for prevention or treatment of osteoporosis
EP4026552A2 (en) Composition for ameliorating premenstrual syndrome symptoms, including chrysanthemum sibiricum extract
KR100638344B1 (en) Composition comprising the crude drug extract for improving eye symptoms of VDT syndrome
KR100750879B1 (en) A pharmaceutical composition comprising the extract of Meliae Cortex for treating or preventing allergic disease
KR100446061B1 (en) Pharmaceutical composition and health improving food for prevention or treatment of hangover comprising microspherical crude drug powder having organic solvent adsorptive activity
KR102297398B1 (en) Composition for health food for improving of respiratory diseases caused by fine dust comprising extract of Liriope platyphylla, Glycyrrhiza uralensis and Aronia as an effective component
KR20200071380A (en) Composition for improving premenstrual syndrome symptom comprising extract of Aucklandiae radix
KR102455690B1 (en) Anti-cancer composition comprising an extract of Elaeocarpus sylvestris or purified extract thereof as an active ingredient

Legal Events

Date Code Title Description
GRNT Written decision to grant